ACUTE AND CHRONIC ACTIVE ANTIBODY MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS: PROGNOSIS AND TREATMENT

被引:0
|
作者
Yilmaz, Vural Taner [1 ]
Kocak, Huseyin [1 ]
Suleymanlar, Gultekin [1 ]
Cetinkaya, Ramazan [1 ]
Akkaya, Bahar [2 ]
Akbas, Halide [3 ]
Koksoy, Sadi [4 ]
Kisaoglu, Abdullah [5 ]
Aydinli, Bulent [5 ]
机构
[1] Akdeniz Univ, Sch Med, Dept Internal Med, Div Nephrol, Antalya, Turkey
[2] Akdeniz Univ, Sch Med, Dept Pathol, Antalya, Turkey
[3] Akdeniz Univ, Sch Med, Dept Biochem, Antalya, Turkey
[4] Akdeniz Univ, Sch Med, Dept Clin Immunol, Antalya, Turkey
[5] Akdeniz Univ, Sch Med, Dept Gen Surg, Antalya, Turkey
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
P499
引用
收藏
页码:527 / 527
页数:1
相关论文
共 50 条
  • [31] Real Word Evidence of the Effectiveness of the Treatment of Antibody Mediated Rejection in Kidney Transplant Recipients
    Divard, G.
    Naser, S.
    Al-Awadhi, S.
    Debiais, C.
    Maanaoui, M.
    Juric, I.
    Castro, M. R.
    Kamar, N.
    Gueguen, J.
    Crespo, M.
    Aubert, O.
    Alexandre, L.
    Lefaucheur, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S411 - S412
  • [32] EFFECTS OF A STANDARDIZED TREATMENT APPROACH ON KIDNEY TRANSPLANT RECIPIENTS WITH ANTIBODY-MEDIATED REJECTION
    Mirioglu, Safak
    Uludag, Omer
    Aksoy, Elif
    Caliskan, Yasar
    Ozluk, Yasemin
    Usta-Akgul, Sebahat
    Ucar, Ali Riza
    Yazici, Halil
    Kilicaslan, Isin
    Turkmen, Aydin
    Sever, Mehmet Sukru
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [33] TOCILIZUMAB TREATMENT IN DSA POSITIVE ANTIBODY MEDIATED REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS
    Cseprekal, Orsolya
    Marton, Adrienn
    Molnar, Sara
    Patonai, Attila
    Attila, Fintha
    Micsik, Tamas
    Szilard, Torok
    Wagner, Laszlo
    Kobori, Laszlo
    Remport, Adam
    [J]. TRANSPLANT INTERNATIONAL, 2021, 34 : 292 - 292
  • [34] TOCILIZUMAB TREATMENT IN DSA POSITIVE ANTIBODY MEDIATED REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS
    Cseprekal, Orsolya
    Marton, Adrienn
    Molnar, Sara
    Patonai, Attila
    Fintha, Attila
    Micsik, Tamas
    Torok, Szilard
    Mathe, Zsolt
    Wagner, Laszlo
    Kobori, Laszlo
    Remport, Adam
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 2074 - 2074
  • [35] A comparison of methods of plasmapheresis for the treatment of late antibody mediated rejection in kidney transplant recipients
    Caliskan, Yasar
    Mirioglu, Safak
    Dirim, Ahmet Burak
    Ozluk, Yasemin
    Yegit, Ozan
    Aksoy, Elif
    Safak, Seda
    Guller, Nurana
    Demir, Erol
    Artan, Ayse Serra
    Oto, Ozgur Akin
    Besisik, Sevgi
    Yazici, Halil
    Turkmen, Aydin
    Lentine, Krista L.
    [J]. THERAPEUTIC APHERESIS AND DIALYSIS, 2023, 27 (03) : 428 - 434
  • [36] Adjunctive Bortezomib Therapy for Treatment of Antibody Mediated Rejection in Kidney Transplant Recipients.
    McDermott, J.
    Lee, J.
    Aull, M.
    Muthukumar, T.
    Hartono, C.
    Serur, D.
    Lee, J.
    Sharma, V.
    Kim, J.
    Watkins, A.
    Kapur, S.
    Suthanthiran, M.
    Dadhania, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 328 - 328
  • [37] Acute Antibody-Mediated Rejection of the Kidney Transplant
    Sladoje-Martinovic, B.
    Orlic, L.
    Zivcic-Cosic, S.
    Racki, S.
    Vuksanovic-Mikulicic, S.
    Maleta, I
    Bubic, I
    Pavletic-Persic, M.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 1036 - 1036
  • [38] Treatment of chronic active antibody-mediated rejection in renal transplant recipients – a single center retrospective study
    Hsien-Fu Chiu
    Mei-Chin Wen
    Ming-Ju Wu
    Cheng-Hsu Chen
    Tung-Min Yu
    Ya-Wen Chuang
    Shih-Ting Huang
    Shang-Feng Tsai
    Ying-Chih Lo
    Hao-Chung Ho
    Kuo-Hsiung Shu
    [J]. BMC Nephrology, 21
  • [39] Treatment of chronic active antibody-mediated rejection in renal transplant recipients - a single center retrospective study
    Chiu, Hsien-Fu
    Wen, Mei-Chin
    Wu, Ming-Ju
    Chen, Cheng-Hsu
    Yu, Tung-Min
    Chuang, Ya-Wen
    Huang, Shih-Ting
    Tsai, Shang-Feng
    Lo, Ying-Chih
    Ho, Hao-Chung
    Shu, Kuo-Hsiung
    [J]. BMC NEPHROLOGY, 2020, 21 (01)
  • [40] Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design
    Nickerson, Peter W.
    Boehmig, Georg A.
    Chadban, Steve
    Kumar, Deepali
    Mannon, Roslyn B.
    van Gelder, Teun
    Lee, James C.
    Adler, Scott
    Chong, Edward
    Djamali, Arjang
    [J]. TRIALS, 2022, 23 (01)